November 14, 2019
FDA: Class I recall of Zimmer Biomet’s ROSA Brain 3.0 Robotic Surgery System
Editor's Note
The Food & Drug Administration on November 7 identified the recall by Zimmer Biomet of its ROSA Brain 3.0 Robotic Surgery System as Class I, the most serious.
The recall was initiated because of a software issue that incorrectly positions the robotic arm. The company has received five complaints related to this issue, including one patient injury. No deaths have been reported.
Distribution dates for the system were April 8, 2016, to March 19, 2019.
Free Daily News
- Augmented reality gains FDA nod, 10k-case milestone in orthopedics, strides in outpatient surgery
- Smart patient selection anchors DISC’s high-acuity spine ASC model
- Postop opioid prescriptions following outpatient surgery see steep, sustained fall
- Study: Bariatric surgery offers cost, survival benefits for cirrhosis patients
- AI monitoring, remote surgery advance
- Rethinking OR routines reduces waste, costs while protecting environment
- Proposed Oregon legislation blocks AI tools from using 'nurse' title
- Communications skills keep surgical patients engaged, informed
- Study: Daytime meals protect heart health in night shift workers
- Borescope inspections reveal widespread contamination in lumened surgical instruments
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement